<DOC>
	<DOCNO>NCT02552836</DOCNO>
	<brief_summary>The primary aim randomize control trial determine acute antidepressant efficacy interpersonal psychotherapy ( IPT ) depress patient Parkinson ` Disease .</brief_summary>
	<brief_title>Efficacy Psychotherapy Depressed Parkinson ` Disease Patients</brief_title>
	<detailed_description>The primary aim study determine whether IPT efficacious intervention control non-specific factor ( i.e. , supportive psychotherapy ) reduce depressive symptom . A secondary aim determine whether IPT well supportive therapy improve quality life , interpersonal functioning , attachment patter , motor symptom , whether treatment gain durable 6-months follow-up . An exploratory aim study identify moderator mediator treatment outcome . Patients meet study criterion randomly assign either 12 session IPT 12 session supportive therapy . The primary efficacy measure ( Hamilton Depression Rating Scale ) administer baseline , week 6 12 , 6 month follow-up .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Outpatients idiopathic Parkinson 's disease stag 1 3 modify Hohn &amp; Yahr Clinical Staging Scale Diagnosis depressive disorder Score ≥ 12 17item Hamilton Depression Rating Scale Living independently History bipolar disorder psychotic symptom ( drug induce ) Substancerelated disorder last 12 month Acutely suicidal history suicide attempt past 5 year Presence cognitive deficit ( i.e. , score ≤ 24 Mini Mental Status Exam ) history significant cognitive disorder Presence significant neurological problem Presence unstable comorbid medical condition Currently receive psychotherapy Unable attend weekly therapy session</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>